Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH notice announces that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T11:58:44.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:34:54.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T14:38:52.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The study record view displays a 403 Forbidden message instead of trial details, with a link back to Home.
    Difference
    0.5%
    Check dated 2026-10-03T14:29:46.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a minimal error page and a Home link; a site revision note (Revision: v3.7.0) is shown, and large blocks of previously visible study data are removed.
    Difference
    29%
    Check dated 2026-09-19T18:31:02.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6 from v3.6.5, indicating a new version of the page documentation. This is a metadata update and does not alter the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-29T20:17:27.000Z thumbnail image

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.